FTXH

Fund Description
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the Nasdaq US Smart Pharmaceuticals Index. The Nasdaq US Smart Sector Index Family tracks a number of United States (US) economic sectors and selects securities for each sector based upon liquidity and then ranks the securities based on a three factor methodology incorporating volatility, value and growth. The Nasdaq US Smart Sector Index Family is a modified factor weighted index. The value of the Index equals the aggregate value of the Index share weights, also known as the Index Shares, of each of the Index Securities multiplied by each such security s Last Sale Price, and divided by the divisor of the Index. The divisor serves the purpose of scaling such aggregate value to a lower order of magnitude which is more desirable for reporting purposes. The Indexes began on July 8, 2016 at a base value of 1000. Index eligibility is limited to specific security types only. The security types eligible for the Index include common stocks, ordinary shares, depositary receipts (both American and Global), depositary shares, shares of beneficial interest or limited partnership interests and tracking stocks.
Fund Profile
Fund Name First Trust Nasdaq Pharmaceuticals ETF
Fund Exchange Ticker FTXH
Fund Sponsor First Trust
Fund ISIN US33738R8372
Net Expense Ratio 0.60 %
Fund Inception Date 20 September 2016
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq US Smart Pharmaceuticals Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 June 2019
Asset Under Management 6.31 Million (USD)
1 Month Total Return 2.53 %
Year To Date Return 10.45 %
1 Year Total Return -3.56 %
3 Year Annualized Total Return
NAV 21.03
Share Outstanding 300,002
Top 10 Holdings (21 June 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ABBOTT LABORATORIES ABT EQUI 0.0910000000
MERCK & CO. INC. MRK EQUI 0.0864000000
PFIZER INC PFE EQUI 0.0837000000
ELI LILLY & CO LLY EQUI 0.0760000000
HORIZON THERAPEUTICS PLC HZNP EQUI 0.0681000000
CATALENT INC CTLT EQUI 0.0512000000
ZOETIS INC ZTS EQUI 0.0498000000
JOHNSON & JOHNSON JNJ EQUI 0.0432000000
JAZZ PHARMACEUTICALS PLC JAZZ EQUI 0.0399000000
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0397000000